- Home
- KIDS vs PACB Comparison
KIDS vs PACB Comparison
Compare KIDS & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIDS | PACB |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.9M | 459.0M |
| IPO Year | 2016 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KIDS | PACB |
|---|---|---|
| Price | $17.64 | $1.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $24.67 | $2.10 |
| AVG Volume (30 Days) | 118.2K | ★ 5.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,049,000.00 | $93,468,000.00 |
| Revenue This Year | $14.07 | $11.22 |
| Revenue Next Year | $11.85 | $12.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.95 | 3.04 |
| 52 Week Low | $15.34 | $0.85 |
| 52 Week High | $26.40 | $2.73 |
Technical Indicators
Market Signals| Indicator | KIDS | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 32.36 |
| Support Level | $17.62 | $1.18 |
| Resistance Level | $19.36 | $1.37 |
| Average True Range (ATR) | 1.02 | 0.10 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 46.09 | 6.25 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.